BioSpace News Archive

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced that it has been granted Small and Medium-Sized Enterprise status by the European Medicines Agency’s Micro, Small and Medium-Sized Enterprise office.

Mr. Kemp Will Build Micron Medical’s Commercial Organization and Prepare Company for Market Launch of First and Only Implantable Nerve Stimulator System for Overactive Bladder

Interventional radiologists participating in a collaborative house call model in rural Indiana helped reduce emergency department use by 77 percent and hospital readmissions by 50 percent for nearly 1,000 elderly homebound patients with chronic illnesses, according to research presented during a virtual session of the Society of Interventional Radiology’s 2020 Annual Scientific Meeting on June 15.

As robots gain attention as weapons to fight the spread of Coronavirus globally, Blue Ocean Robotics announced that it has been included in Robotics Business Review’s list of the 50 most influential robotics companies in the world (RBR50) for its UVD Robots

Sedative that Received FDA Emergency Use Authorization Now Available from Fresenius Kabi for use in Mechanically Ventilated COVID-19 patients FDA authorization allows importation of Propoven 2% (propofol 20 mg per mL), double the concentration of the widely used drug Diprivan ® COVID-19 patients requiring mechanical ventilation increased demand for propofol worldwide LAKE ZURICH, Ill.--( BUSINESS WIRE )-- Fresenius Kabi announced today t

Bayer to Present Results from Head-to-Head PK Comparison Study of Jivi ® Versus Adynovate ® in Late-Breaker Presentation at the Annual World Federation of Hemophilia Virtual Summit WHIPPANY, N.J.--( BUSINESS WIRE )-- Bayer announced today it will present new data highlighting the results from the first head-to-head study directly comparing the pharmacokinetic (PK) profiles of two extended half-life (EHL) recombinant factor VIII (FVIII) therapies, Jivi ® (

Eye Care Professionals in Zambia to Receive the Inaugural Remote Training via Award-Winning Telemedicine Platform Cybersight amid Coronavirus Pandemic

After a nearly 40-year career with Bayer, Philip Blake, Senior Bayer Representative (SBR) and President of Bayer in the United States, has announced his retirement from this leadership role, effective July 31. Since 2012, Blake has been responsible for all U.S. activities of the worldwide Bayer Group.

Adhering to strict health and safety guidelines, the UX Innovation Practice at Strategy Analytics is once again offering face to face research in California.

Study by CHOP researchers has implications for those seeking to understand the drivers of asthma exacerbations